Gene · 7732
Papers1,998
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,998
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An alternative NURF complex sustains acute myeloid leukemia by regulating the accessibility of insulator regions. | EMBO J | 2023 | 37987160 | PubTator, text mining | PubMed |
| REV7 Monomer Is Unable to Participate in Double Strand Break Repair and Translesion Synthesis but Suppresses Mitotic Errors. | Int J Mol Sci | 2023 | 37958783 | PubTator, text mining | PubMed |
| SuSiE PCA: A scalable Bayesian variable selection technique for principal component analysis. | iScience | 2023 | 37953948 | PubTator, text mining | PubMed |
| Lung SORT LNPs enable precise homology-directed repair mediated CRISPR/Cas genome correction in cystic fibrosis models. | Nat Commun | 2023 | 37951948 | PubTator, text mining | PubMed |
| Nonsense mutation suppression is enhanced by targeting different stages of the protein synthesis process. | PLoS Biol | 2023 | 37943958 | PubTator, text mining | PubMed |
| m1A in CAG repeat RNA binds to TDP-43 and induces neurodegeneration. | Nature | 2023 | 37938769 | PubTator, text mining | PubMed |
| Quantification of evolved DNA-editing enzymes at scale with DEQSeq. | Genome Biol | 2023 | 37932818 | PubTator, text mining | PubMed |
| Harnessing CD3 diversity to optimize CAR T cells. | Nat Immunol | 2023 | 37932456 | PubTator, text mining | PubMed |
| Mammalian Genomic Manipulation with Orthogonal Bxb1 DNA Recombinase Sites for the Functional Characterization of Protein Variants. | ACS Synth Biol | 2023 | 37922210 | PubTator, text mining | PubMed |
| CAG repeat expansions create splicing acceptor sites and produce aberrant repeat-containing RNAs. | bioRxiv | 2023 | 37904984 | PubTator, text mining | PubMed |
| A dual sgRNA library design to probe genetic modifiers using genome-wide CRISPRi screens. | BMC Genomics | 2023 | 37904134 | PubTator, text mining | PubMed |
| Doxycycline-inducible Expression of Proteins at Near-endogenous Levels in Mammalian Cells Using the Sleeping Beauty Transposon System. | Bio Protoc | 2023 | 37900104 | PubTator, text mining | PubMed |
| A Novel Rotavirus Reverse Genetics Platform Supports Flexible Insertion of Exogenous Genes and Enables Rapid Development of a High-Throughput Neutralization Assay. | Viruses | 2023 | 37896813 | PubTator, text mining | PubMed |
| Utilizing AAV-mediated LEAPER 2.0 for programmable RNA editing in non-human primates and nonsense mutation correction in humanized Hurler syndrome mice. | Genome Biol | 2023 | 37872590 | PubTator, text mining | PubMed |
| Developing synthetic tools to decipher the tumor-immune interactome. | Proc Natl Acad Sci U S A | 2023 | 37871202 | PubTator, text mining | PubMed |
| Structural and functional basis of inositol hexaphosphate stimulation of NHEJ through stabilization of Ku-XLF interaction. | Nucleic Acids Res | 2023 | 37870477 | PubTator, text mining | PubMed |
| ORF3c is expressed in SARS-CoV-2-infected cells and inhibits innate sensing by targeting MAVS. | EMBO Rep | 2023 | 37870297 | PubTator, text mining | PubMed |
| A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicity. | J Exp Clin Cancer Res | 2023 | 37858248 | PubTator, text mining | PubMed |
| Inactive S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in human stem cell model of Parkinson's disease. | Sci Rep | 2023 | 37853101 | PubTator, text mining | PubMed |
| Senataxin helicase, the causal gene defect in ALS4, is a significant modifier of C9orf72 ALS G4C2 and arginine-containing dipeptide repeat toxicity. | Acta Neuropathol Commun | 2023 | 37845749 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7732/papers?page=10